For educational purposes only — always consult your healthcare provider.
🤱 Breastfeeding Safety
Zanubrutinib
No information is available on the clinical use of zanubrutinib during breastfeeding. Manufacturer advises discontinuing breastfeeding during treatment and for 2 weeks after the last dose.
Need more information before deciding?
- Safer alternatives to consider
- Why this rating — the full evidence
- Infant side effects to watch for
- Effect on milk supply
Free · No account required
LactSafe